{"title":"Ensuring Healthcare Resilience & Transformation Through Policy","authors":"V. Dennis","doi":"10.30953/tmt.v7.330","DOIUrl":"https://doi.org/10.30953/tmt.v7.330","url":null,"abstract":"","PeriodicalId":320236,"journal":{"name":"Telehealth and Medicine Today","volume":"27 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130160146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Financial Confidence Strategies is derived from Arkwright’s 2019 Telehealth and Medicine Today Journal published paper;Telehealth Financial Variables and Successful Business Models is predicated on a THMT article that was the second most downloaded paper in 2020 amidst the onset of COVID-19 and a global eruption of increased telehealth services. The presentation addresses telehealth growth, scale, ROI, investment strategy, and best practice.
{"title":"Financial Confidence Strategies for Telehealth ROI & Investment Value","authors":"Arkwright Bryan","doi":"10.30953/tmt.v7.350","DOIUrl":"https://doi.org/10.30953/tmt.v7.350","url":null,"abstract":"Financial Confidence Strategies is derived from Arkwright’s 2019 Telehealth and Medicine Today Journal published paper;Telehealth Financial Variables and Successful Business Models is predicated on a THMT article that was the second most downloaded paper in 2020 amidst the onset of COVID-19 and a global eruption of increased telehealth services. The presentation addresses telehealth growth, scale, ROI, investment strategy, and best practice.","PeriodicalId":320236,"journal":{"name":"Telehealth and Medicine Today","volume":"14 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115236749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Discussion focus on the top legal and regulatory issues affecting the delivery and reimbursement of telehealth services during the COVID-19 pandemic and how legislatures and government agencies at federal and state levels are responding in the aftermath to implement permanent changes and enforce fraudulent activities. The session provides valuable insights for startups and existing telemedicine practices seeking to understand strategic planning to optimize market success and maintain a compliant multi-state practice.
{"title":"COVID-19 Pandemic: Utilization and Aftermath of Telehealth Services","authors":"Dunham Charles","doi":"10.30953/tmt.v7.326","DOIUrl":"https://doi.org/10.30953/tmt.v7.326","url":null,"abstract":"Discussion focus on the top legal and regulatory issues affecting the delivery and reimbursement of telehealth services during the COVID-19 pandemic and how legislatures and government agencies at federal and state levels are responding in the aftermath to implement permanent changes and enforce fraudulent activities. The session provides valuable insights for startups and existing telemedicine practices seeking to understand strategic planning to optimize market success and maintain a compliant multi-state practice.","PeriodicalId":320236,"journal":{"name":"Telehealth and Medicine Today","volume":"100 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123812300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Driving Telehealth Equity through Local Libraries & Community Connectivity","authors":"S. Craig","doi":"10.30953/tmt.v7.353","DOIUrl":"https://doi.org/10.30953/tmt.v7.353","url":null,"abstract":"","PeriodicalId":320236,"journal":{"name":"Telehealth and Medicine Today","volume":"93 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114816939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objectives: Effective treatment of patients with type 2 diabetes mellitus requires a multidisciplinary approach. Our study provided telemedicine healthcare delivery, using a model of collaborative drug therapy management (CDTM) protocol incorporating medical nutrition therapy (MNT) interventions by Dietitians and Pharmacists. Methods: We conducted a retrospective chart review of patient data collected between December 2014 and December 2015. We compared five intervention groups of patients (n=12,370) receiving different levels of treatment from Pharmacists, Registered Dietitian/Nutritionist, and/or the Call Center, using Telemedicine consultation techniques over a one-year period. The control group received their supplies through the mail without any contacts with the Call Center, Pharmacists, or Dietitians. The cross-sectional data collected for A1c were analyzed using ANOVA to assess for within-group differences in A1c reduction among groups with different risk factors. Results: Roughly, 18 percent of study participants were identified as high-risk, with a serum A1c level greater than 10%. Lower A1c and low density lipoprotein (LDL) cholesterol levels were reported for patients who received at least four prescription refills over the study period, (-0.113 and -4.931, respectively). Results reveal that average A1c levels for the intervention groups were lower compared to the control group. Overall, interventions led by Dietitians and Pharmacists resulted in a higher reduction in A1c levels in the high-risk group of patients with type 2 diabetes. Conclusions: This study showed that using Telemedicine consultation, led by Dietitians and Pharmacists, resulted in a more effective intervention for patients with diabetes and resulted in a positive change of lowering plasma A1c levels and LDL cholesterol as a secondary outcome. For future study, using the same multidisciplinary intervention and telehealth format, a longitudinal data collected over a minimum of 6-months would allow for tracking of changes in A1c and LDL cholesterol in the individuals with type 2 diabetes. Keywords: Diabetes, Telemedicine, Telehealth, Pharmacist and Dietitian led intervention, A1c, LDL cholesterol
{"title":"Multidisciplinary Team in Ambulatory Management of Diabetes Mellitus Using Telehealth Among a Sample of Medicaid Patients","authors":"Nicole Henley, Dorothy Chen-Maynard, Erin Pablo-Bandong","doi":"10.30953/tmt.v7.309","DOIUrl":"https://doi.org/10.30953/tmt.v7.309","url":null,"abstract":"Objectives: Effective treatment of patients with type 2 diabetes mellitus requires a multidisciplinary approach. Our study provided telemedicine healthcare delivery, using a model of collaborative drug therapy management (CDTM) protocol incorporating medical nutrition therapy (MNT) interventions by Dietitians and Pharmacists. Methods: We conducted a retrospective chart review of patient data collected between December 2014 and December 2015. We compared five intervention groups of patients (n=12,370) receiving different levels of treatment from Pharmacists, Registered Dietitian/Nutritionist, and/or the Call Center, using Telemedicine consultation techniques over a one-year period. The control group received their supplies through the mail without any contacts with the Call Center, Pharmacists, or Dietitians. The cross-sectional data collected for A1c were analyzed using ANOVA to assess for within-group differences in A1c reduction among groups with different risk factors. Results: Roughly, 18 percent of study participants were identified as high-risk, with a serum A1c level greater than 10%. Lower A1c and low density lipoprotein (LDL) cholesterol levels were reported for patients who received at least four prescription refills over the study period, (-0.113 and -4.931, respectively). Results reveal that average A1c levels for the intervention groups were lower compared to the control group. Overall, interventions led by Dietitians and Pharmacists resulted in a higher reduction in A1c levels in the high-risk group of patients with type 2 diabetes. Conclusions: This study showed that using Telemedicine consultation, led by Dietitians and Pharmacists, resulted in a more effective intervention for patients with diabetes and resulted in a positive change of lowering plasma A1c levels and LDL cholesterol as a secondary outcome. For future study, using the same multidisciplinary intervention and telehealth format, a longitudinal data collected over a minimum of 6-months would allow for tracking of changes in A1c and LDL cholesterol in the individuals with type 2 diabetes. Keywords: Diabetes, Telemedicine, Telehealth, Pharmacist and Dietitian led intervention, A1c, LDL cholesterol","PeriodicalId":320236,"journal":{"name":"Telehealth and Medicine Today","volume":"61 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125649509","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
F. Campion, L. Duffy, A. Burgman, R. Rojas, L. Sangaralingham, Peter Sylvester
Importance: This very large claims data analysis documents widespread adoption of telehealth use by patients with diabetes during the first year of the COVID-19 pandemic, giving us insight into the potential role of telehealth as we enter a stage of “new normal” of healthcare delivery in the U.S. Objective: The COVID-19 Telehealth Impact Study was designed to describe the natural experiment of telehealth adoption during the pandemic. This focused analysis can assist program development for care of large populations of patients with diabetes. Design, Setting, Participants: In March 2020, the MITRE Corporation and Mayo Clinic founded the COVID-19 Healthcare Coalition (C19HCC) and Telehealth Impact Study to respond to the pandemic. We report trends using a data set of over 2 billion healthcare claims covering over 50% of private insurance activity in the U.S. (January 2019-March 2021). Main Outcomes and Measures: We compared rates of telehealth use in the one-year pre and one-year post onset of the COVID-19 pandemic among a population of 8,339,633 patients with diabetes. Results: Compared to a baseline of very low telehealth use in 2019, there was rapid adoption of telehealth by patients with diabetes in Spring 2020. 27% of diabetics used telehealth in Q2 2020 and use rates declined in the ensuing months to approximately 13%. Diabetics and their providers used telehealth to address a wide variety of health problems. 77% of telehealth visits addressed diabetes, 53% hypertension and over 40% of visits addressed mental and behavioral health diagnoses. Audio-only (telephone visits) accounted for a substantial portion of telehealth encounters (10.0- 16.3%) and will be an important consideration for future telehealth planning. Over the course of the first 12 months of the pandemic, 98% diabetics who used telehealth used 4 or fewer telehealth visit. Conclusions and Relevance: We believe that telehealth will quickly become a best practice for routine care of patients with diabetes and other chronic conditions. Telehealth interactions 2-4 times per year supplemented with remote monitoring for glucose, blood pressure and weight have the potential to greatly enhance patient care. Further research will be needed to measure the telehealth impact on glycemic control, patient satisfaction and other outcomes. We encourage CMS and other payers to embrace and promote use of telehealth based on this real-world experience of patients and providers during the pandemic.
{"title":"Trends in Telehealth Care for Diabetes During the COVID-19 Pandemic","authors":"F. Campion, L. Duffy, A. Burgman, R. Rojas, L. Sangaralingham, Peter Sylvester","doi":"10.30953/tmt.v7.311","DOIUrl":"https://doi.org/10.30953/tmt.v7.311","url":null,"abstract":"Importance: This very large claims data analysis documents widespread adoption of telehealth use by patients with diabetes during the first year of the COVID-19 pandemic, giving us insight into the potential role of telehealth as we enter a stage of “new normal” of healthcare delivery in the U.S.\u0000Objective: The COVID-19 Telehealth Impact Study was designed to describe the natural experiment of telehealth adoption during the pandemic. This focused analysis can assist program development for care of large populations of patients with diabetes. \u0000Design, Setting, Participants: In March 2020, the MITRE Corporation and Mayo Clinic founded the COVID-19 Healthcare Coalition (C19HCC) and Telehealth Impact Study to respond to the pandemic. We report trends using a data set of over 2 billion healthcare claims covering over 50% of private insurance activity in the U.S. (January 2019-March 2021).\u0000Main Outcomes and Measures: We compared rates of telehealth use in the one-year pre and one-year post onset of the COVID-19 pandemic among a population of 8,339,633 patients with diabetes.\u0000Results: Compared to a baseline of very low telehealth use in 2019, there was rapid adoption of telehealth by patients with diabetes in Spring 2020. 27% of diabetics used telehealth in Q2 2020 and use rates declined in the ensuing months to approximately 13%. Diabetics and their providers used telehealth to address a wide variety of health problems. 77% of telehealth visits addressed diabetes, 53% hypertension and over 40% of visits addressed mental and behavioral health diagnoses. Audio-only (telephone visits) accounted for a substantial portion of telehealth encounters (10.0- 16.3%) and will be an important consideration for future telehealth planning. Over the course of the first 12 months of the pandemic, 98% diabetics who used telehealth used 4 or fewer telehealth visit.\u0000Conclusions and Relevance:\u0000We believe that telehealth will quickly become a best practice for routine care of patients with diabetes and other chronic conditions. Telehealth interactions 2-4 times per year supplemented with remote monitoring for glucose, blood pressure and weight have the potential to greatly enhance patient care. Further research will be needed to measure the telehealth impact on glycemic control, patient satisfaction and other outcomes. We encourage CMS and other payers to embrace and promote use of telehealth based on this real-world experience of patients and providers during the pandemic.","PeriodicalId":320236,"journal":{"name":"Telehealth and Medicine Today","volume":"33 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131874384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
As telehealth is a growing form of healthcare delivery across the world, particularly after the COVID-19 pandemic, it’s impact on patient populations particularly in aboriginal and rural communities boasts many questions. As the health disparities between aboriginal groups living in rural areas on reserves and the rest of the Canadian demographics remain to be mountainous, telemedicine is often seen as the new way forward in reducing these healthcare gaps. Presently, much research has been conducted on these cohorts, particularly in the health equity atmosphere. However, much of this research lacks a comprehensive framework or tool in which it analyzes the efficacy of outcomes. In this review paper, the quadruple aim – the ideal standard of care which North American health systems seek to conform to – will be used to analyze telemedicine performance, and assert evidence-based recommendations for improvement. Therefore, this paper seeks to conduct a thematic analysis on the various issues and barriers to telemedicine delivery and usage in aboriginal populations with respect to the quadruple aim as well as identifying evidence-based solutions to alleviate some of these concerns and bolster care.
{"title":"Conducting a Global Quadruple Aim Thematic Analysis of Telemedicine Performance in Rural Indigenous Populations and Evidence-Based Recommendations for Improvement","authors":"H. Naqvi","doi":"10.30953/tmt.v7.301","DOIUrl":"https://doi.org/10.30953/tmt.v7.301","url":null,"abstract":"As telehealth is a growing form of healthcare delivery across the world, particularly after the COVID-19 pandemic, it’s impact on patient populations particularly in aboriginal and rural communities boasts many questions. As the health disparities between aboriginal groups living in rural areas on reserves and the rest of the Canadian demographics remain to be mountainous, telemedicine is often seen as the new way forward in reducing these healthcare gaps. \u0000Presently, much research has been conducted on these cohorts, particularly in the health equity atmosphere. However, much of this research lacks a comprehensive framework or tool in which it analyzes the efficacy of outcomes. In this review paper, the quadruple aim – the ideal standard of care which North American health systems seek to conform to – will be used to analyze telemedicine performance, and assert evidence-based recommendations for improvement. \u0000Therefore, this paper seeks to conduct a thematic analysis on the various issues and barriers to telemedicine delivery and usage in aboriginal populations with respect to the quadruple aim as well as identifying evidence-based solutions to alleviate some of these concerns and bolster care. \u0000 ","PeriodicalId":320236,"journal":{"name":"Telehealth and Medicine Today","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129796066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Tory Cenaj, Lisa M. Lavin, B. Erickson, R. Farraj, Florian Otto, William J. Hercules, Nir Shalom, E. Zimlichman, Shayan Vyas, Russell Glass, Andrew Philip
Each year Telehealth and Medicine Today reaches out to journal board members, annual ConV2X Symposium speakers and ecosystem subject matter experts to share their views and perspectives for the near term in the telehealth and virtual care marketplace. The article presents insights into where authors anticipate market opportunities and gaps that must be addressed for the most appropriate and effective patient care programs globally and regionally for 2022.
{"title":"Telehealth and Medicine Today 2022 Market Predictions","authors":"Tory Cenaj, Lisa M. Lavin, B. Erickson, R. Farraj, Florian Otto, William J. Hercules, Nir Shalom, E. Zimlichman, Shayan Vyas, Russell Glass, Andrew Philip","doi":"10.30953/tmt.v7.312","DOIUrl":"https://doi.org/10.30953/tmt.v7.312","url":null,"abstract":"Each year Telehealth and Medicine Today reaches out to journal board members, annual ConV2X Symposium speakers and ecosystem subject matter experts to share their views and perspectives for the near term in the telehealth and virtual care marketplace. The article presents insights into where authors anticipate market opportunities and gaps that must be addressed for the most appropriate and effective patient care programs globally and regionally for 2022.","PeriodicalId":320236,"journal":{"name":"Telehealth and Medicine Today","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125927918","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Emergency Medical Technicians’ Perspectives on a Telehealth Facilitator Role to Expand Home-Based Primary Care: Pilot Study Resultss","authors":"","doi":"10.30953/tmt.v7.283","DOIUrl":"https://doi.org/10.30953/tmt.v7.283","url":null,"abstract":"","PeriodicalId":320236,"journal":{"name":"Telehealth and Medicine Today","volume":"25 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114251294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：